Thomas Cash, Araz Marachelian, Steven G. DuBois, Yueh-Yun Chi, Anahit Baregamyan, Susan G. Groshen, Hunter C. Jonus, Anasheh Shamirian, Mary Crowley, Fariba Goodarzian, Patricia T. Acharya, Bruce Pawel, Amy K. Erbe, Ankita Shahi, Jen Zaborek, Eleanor Kennedy, Shahab Asgharzadeh, Judith G. Villablanca, Navin Pinto, Brian D. Weiss, Yael P. Mossé, Ami V. Desai, Margaret E. Macy, Meaghan Granger, Kieuhoa T. Vo, Paul M. Sondel, Katherine K. Matthay, Julie R. Park, Kelly C. Goldsmith. "Phase I Study of
            <sup>131</sup>
            I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-02612